ReviewBrazilian journal of otorhinolaryngology
Thyroid leiomyosarcoma: presentation of two cases and review of the literature.
Review in Brazilian journal of otorhinolaryngology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 20 citations in OpenAlex.
- Integrative diagnostic approach in a rare case of primary thyroid leiomyosarcoma with distant metastasis: a case report and literature review.Gland surgery · 2025Article
- Primary Leiomyosarcoma of the Thyroid.Head and neck pathology · 2025Article
- Primary leiomyosarcoma of the thyroid with concurrent papillary thyroid cancer: a rare case report and a review of literature.Thyroid research · 2023Article
- Neck Surgery for Non-Well Differentiated Thyroid Malignancies: Variations in Strategy According to Histopathology.Cancers · 2023Review
- Primary Mesenchymal Tumors of the Thyroid Gland: A Modern Retrospective Cohort Including the First Case of TFE3-Translocated Malignant Perivascular Epithelioid Cell Tumor (PEComa).Head and neck pathology · 2022Article
- Primary thyroid leiomyosarcoma with transvenous extension to the right atrium: a case report.European heart journal. Case reports · 2022Article
- Primary thyroid leiomyosarcoma: a diagnostic and therapeutic challenge.BMJ case reports · 2021Review
- Primary Leiomyosarcoma of the Thyroid Gland - A Rare Malignancy.European endocrinology · 2019Article
- Primary leiomyosarcoma of the thyroid gland with prior malignancy and radiotherapy: A case report and review of literature.World journal of clinical cases · 2019Article
- Clinicopathological features of primary thyroid leiomyosarcoma without Epstein-Barr virus infection: A case report.Oncology letters · 2019Article
- Primary thyroid leiomyosarcoma: a case report and review of the literature.Il Giornale di chirurgiaReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionLeiomyosarcoma is a tumor which is rarely seen in the thyroid gland. The diagnosis may be difficult and the treatment is controversial.
objectiveThe objective of the study is to review the literature about a rare malignant disease of the thyroid gland which has high mortality.
methodsTwo cases of thyroid leiomyosarcoma are presented and the previous 23 cases in the current literature are reviewed.
resultsA total of 25 cases of thyroid leiomyosarcoma are reviewed; the most common complaint was rapidly growing anterior neck mass, and ten of the 25 patients had distant metastasis at the initial admission. Fifteen of the 25 patients died with the disease in the first 12 months after the diagnosis.
conclusionThe differential diagnosis of thyroid leiomyosarcoma is important and should be performed with other malignancies of the gland, especially with anaplastic carcinoma. The prognosis is poor and there is no consensus regarding the treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.